NeuroBytes: Amyloid-Related Imagin Abnormalities (ARIA)
Course Description
Patients treated with anti-amyloid monoclonal antibodies may develop brain bleeding or brain swelling referred to as Amyloid-Related Imaging Abnormalities, or ARIA. This video focuses on how these complications manifest on MRI. Careful monitoring of these patients is required so that those at highest risk of adverse outcomes can have their infusions held before developing serious complications.
Learning Objectives
As a result of this program the learner will be able to:
- Recognize and manage amyloid related imaging abnormalities
Date of Release
January 26, 2024
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete
Terms of Use.
Faculty & Disclosures
CAMERON STEWART, MD
Resident Physician
Brown Department of Neurology
Providence, RI
* Dr. Stewart has nothing to disclose.
Editor
Reviewer
Resident Physician
Brown Department of Neurology
Providence, RI
* Dr. Stewart has nothing to disclose.
Editor
ANELYSSA D'ABREU, MD, PhD, MPH
Associate Professor of Neurology
University of Virginia
Charlottesville, VA
*The institution of Dr. D'Abreu has received research support from Alzheimer's and Related Diseases Research Award Fund (Virginia Center on Aging in the College of Health Professions). Dr. D'Abreu has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Primed
Reviewer
CALLI LEIGHANN COOK, DNP, FNP-C
Clinical Assistant Professor, Emory Nell Hodgson
Woodruff School of Nursing
Nurse Practitioner, Emory Brain Health Center
Atlanta, GA
*Dr. Cook has nothing to disclose.
Voiceover Artist
TESSA DAHLGREN
eLearning Production Program Manager
Minneapolis, MN
*Ms. Dahlgren has nothing to disclose.
NeuroBytes Staff
Xiaoyu Sun, Associate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.
Robert Rook, eLearning Manager
Minneapolis, MN
*Mr. Rook has nothing to disclose.
Zach Cramer, eLearning Program Manager
Minneapolis, MN
*Mr. Cramer has nothing to disclose.